Advertisement
Advertisement

IBIO

IBIO logo

iBio, Inc. Common Stock

1.43
USD
Sponsored
-0.04
-2.72%
Aug 26, 15:58 UTC -4
Closed
exchange

After-Market

1.44

+0.01
+0.35%

iBio, Inc. Common Stock Profile

About

Ibio Inc., formerly known as iBioPharma Inc., is a biopharmaceutical company that primarily focuses on developing vaccines and therapeutic proteins based upon its plant-based iBioLaunch platform technology. The Company's hydroponically grown green plants can be used for the development and manufacture of proteins applicable to a range of disease agents, such as influenza, sleeping sickness, anthrax, plague, human papillomavirus and veterinary influenza applications. IBio, Inc. is headquartered in Newark, Delaware.

Info & Links

CEO

Martin Brenner

Headquarters

11750 Sorrento Valley Road, Suite 200
San Diego, CA 92121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.ibioinc.com

Auditor

GRASSI & Co., CPAs, P.C.

Share holders

21

Employees

20

iBio, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

71.29M

Enterprise Value

23.66M

Enterprise Value/EBITDA(ttm)

-0.84

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.66

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

50.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

-2075.38%

Return on Equity(ttm)

-53.86%

Return on Invested Capital(ttm)

-70.77%

Return on Assets(ttm)

-46.48%

Income Statement

Revenue(ttm)

300.00K

Revenue Per Share(ttm)

0.01

Gross Profit(ttm)

300.00K

EBITDA(ttm)3

-28.05M

Net Income Available to Common(ttm)

-27.61M

Diluted EPS(ttm)

-0.58

Share Statistics

Beta (5Y Monthly)

1.30

52-Week Change

69.07%

S&P 500 52-Week Change

19.02%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

49.68M

Dividend Yield

0.00%

Float4

48.31M

% Held by Insiders

2.75%

% Held by Institutions

7.90%

Balance Sheet

Total Cash(mrq)

74.80M

Total Cash Per Share(mrq)

1.51

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

11.88%

Quick Ratio(mrq)

11.88%

Book Value Per Share(mrq)

2.24

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.14

Free Cash Flow(ytd)

-17.55M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement